To mark the 20th anniversary of Medicare Part D, the MAPRx Coalition brought together the policymakers who drafted Part D, the officials who implement and oversee the benefit today, and the patient advocates who have seen its impact firsthand at…
Medicare Part D was created through the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003 and implemented in 2006 to address a major Medicare gap: the lack of broad outpatient prescription drug coverage, making the program a cornerstone…
During the Annual Open Enrollment Period for Medicare prescription drug coverage (Part D), Medicare beneficiaries are given the opportunity to select a new plan for the upcoming year. The 2027 plan year’s open enrollment period is October 15 – December…
In December 2025, the Centers for Medicare & Medicaid Services (CMS) announced two major initiatives to expand access to obesity management medications for Medicare and Medicaid beneficiaries: the Medicare GLP-1 Bridge program and the BALANCE (Better Approaches to Lifestyle and…
Enacted in 2022, the Inflation Reduction Act (IRA) introduced significant reforms aimed at reducing the financial burden of prescription drug costs for Medicare Part D beneficiaries. A new report from MAPRx, however, shows that as a larger share of liability…
The MAPRx coalition has championed policies in Part D that improve the affordability of medications and beneficiary access to those medications, including provisions of the Inflation Reduction Act (IRA) that establish an out-of-pocket cap in Part D and the Medicare…
The Medicare prescription drug benefit (Medicare Part D) has been an enormous help to beneficiaries and a policy success story by providing coverage for prescription drugs. The program filled a major gap in Medicare’s benefits and has done so with…
The MAPRx Coalition submitted comments to CMS urging that as the MDPNP is implemented, it is imperative that the program is informed by the experiences and needs of beneficiaries living withchronic diseases and conditions. Read for more.